Boswellic acids: a group of medicinally important compounds.
about
Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro EvidencesTriterpenoids as potential agents for the chemoprevention and therapy of breast cancer.Terpenoids as potential chemopreventive and therapeutic agents in liver cancerBoswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells.Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA familySynthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.Therapeutic potential of boswellic acids: a patent review (1990-2015).Chemistry and biology of essential oils of genus boswellia.Quantitative Determination of 3-O-Acetyl-11-Keto-βBoswellic Acid (AKBA) and Other Boswellic Acids in Boswellia sacra Flueck (syn. B. carteri Birdw) and Boswellia serrata Roxb.PARP cleavage and perturbance in mitochondrial membrane potential by 3-α-propionyloxy-β-boswellic acid results in cancer cell death and tumor regression in murine models.Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).Phytochemistry and Pharmacological Studies of Citrus macroptera: A Medicinal Plant Review.A novel cyano derivative of 11-keto-β-boswellic acid causes apoptotic death by disrupting PI3K/AKT/Hsp-90 cascade, mitochondrial integrity, and other cell survival signaling events in HL-60 cells.Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells.Combination of quantitative analysis and chemometric analysis for the quality evaluation of three different frankincenses by ultra high performance liquid chromatography and quadrupole time of flight mass spectrometry.Reversal of boswellic acid analog BA145 induced caspase dependent apoptosis by PI3K inhibitor LY294002 and MEK inhibitor PD98059.Quantification of AKBA in Boswellia sacra Using NIRS Coupled with PLSR as an Alternative Method and Cross-Validation by HPLC.Chemical, molecular and structural studies of Boswellia species: β-Boswellic Aldehyde and 3-epi-11β-Dihydroxy BA as precursors in biosynthesis of boswellic acids.Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications.
P2860
Q28546967-3EBF5915-F771-4FE4-A707-432082746C6EQ34675534-EB15C335-EED2-4B68-BF2D-C23E9C0FB533Q35238085-5023D70A-4990-40CB-BAC4-10B3D7AACBFFQ36000279-CD8CC2E5-389C-446B-BDFD-4F231B0D7BBDQ36435782-1AED3F83-FD3F-486B-8643-CC85FEB9FE03Q38941880-89BDFEAE-8138-4F0C-B897-39EF3074F617Q38959022-53BDFB19-2A81-439C-A269-03D113A2E74BQ39243722-6DC9EDAB-3833-45AD-909F-0CB702ED02A6Q39249284-97C1CC32-A418-45BA-9B27-56FDE4F25C60Q39308503-AF87E765-ACBE-48B0-BFD7-381D19E2C333Q39388546-0EB63B20-A645-453F-9CB8-3137A67191C8Q39455806-EDE8CA0D-BA6F-4B87-9223-4AA33ABC00E6Q39507595-FF64E004-724D-40D2-8605-59DC0B498754Q39768734-F28DCDB2-2AC0-41B1-AE8A-2A3E2E6ADCD7Q46692349-1003101E-BF85-432F-86ED-438C6FCE2857Q47772398-6C3BABAF-53F9-42AB-B98E-41AC9DE26E01Q48020711-2E20E3FD-F570-40DA-8F15-6FD0DD28EB70Q55346414-7ABD5C35-4D9A-4FCC-AAA8-FEAA0011C0D7Q55347286-AD10462A-723C-4FAD-8D10-1715ABCFD915
P2860
Boswellic acids: a group of medicinally important compounds.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Boswellic acids: a group of medicinally important compounds.
@en
Boswellic acids: a group of medicinally important compounds.
@nl
type
label
Boswellic acids: a group of medicinally important compounds.
@en
Boswellic acids: a group of medicinally important compounds.
@nl
prefLabel
Boswellic acids: a group of medicinally important compounds.
@en
Boswellic acids: a group of medicinally important compounds.
@nl
P2860
P356
P1476
Boswellic acids: a group of medicinally important compounds
@en
P2093
Ghulam Nabi Qazi
Subhash Chandra Taneja
P2860
P356
10.1039/B809437N
P577
2009-01-01T00:00:00Z